# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4836402 | B | Inhibition of human liver mitochondrial KMO assessed as reduction in 3-HK metabolite formation using L-kynurenine as substrate preincubated for 5 mins followed by substate addition and measured after 30 mins by LC-MS/MS analysis | Homo sapiens | 17 | mitochondrion format | Scientific Literature | ||
2. | ALA4836403 | A | Metabolic stability in human liver microsomes assessed as intrinsic clearance incubated for 30 mins in presence of NADPH measured per mg protein | Homo sapiens | 17 | microsome format | Scientific Literature | ||
3. | ALA4836404 | A | Metabolic stability in rat liver microsomes assessed as intrinsic clearance incubated for 30 mins in presence of NADPH measured per mg protein | Rattus norvegicus | 17 | microsome format | Scientific Literature | ||
4. | ALA4836405 | P | Glutathione reactivity assessed as dansylatedGSH-compound conjugate formation in presence of human liver microsomes by fluorescence detector based HPLC analysis | 17 | microsome format | Scientific Literature | |||
5. | ALA4836414 | A | Plasma concentration in cynomolgus monkey at 5 mg/kg, po measured after 2 hrs of administration | Macaca fascicularis | 2 | organism-based format | Scientific Literature | ||
6. | ALA4836415 | A | Drug uptake in cynomolgus monkey striatum at 5 mg/kg, po measured after 2 hrs of administration | Macaca fascicularis | 2 | organism-based format | Scientific Literature | ||
7. | ALA4836416 | A | Ratio of drug level in cynomolgus monkey striatum to plasma at 5 mg/kg, po measured after 2 hrs of administration | Macaca fascicularis | 2 | organism-based format | Scientific Literature | ||
8. | ALA4836417 | F | Neuroprotective activity in R6/2 transgenic mouse model assessed as reduction in 3-HK level in striatum at 25 to 100 mg/kg, po measured after 1 hr | Mus musculus | 1 | organism-based format | Scientific Literature | ||
9. | ALA4836418 | F | Neuroprotective activity in R6/2 transgenic mouse model assessed as increase in KYNA level in striatum at 25 to 100 mg/kg, po measured after 1 hr relative to control | Mus musculus | 1 | organism-based format | Scientific Literature | ||
10. | ALA4836419 | F | Neuroprotective activity in R6/2 transgenic mouse model assessed as reduction in 3-HK level in striatum at 100 mg/kg, po measured after 24 hrs | Mus musculus | 1 | organism-based format | Scientific Literature | ||
11. | ALA4836423 | A | Clearance in cynomolgus monkey at 0.482 mg/kg, iv | Macaca fascicularis | 1 | organism-based format | Scientific Literature | ||
12. | ALA4836424 | A | Half life in cynomolgus monkey plasma at 0.482 mg/kg, iv | Macaca fascicularis | 1 | organism-based format | Scientific Literature | ||
13. | ALA4836425 | A | Oral bioavailability in cynomolgus monkey at 5 mg/kg | Macaca fascicularis | 1 | organism-based format | Scientific Literature | ||
14. | ALA4836426 | A | Protein binding in cynomolgus monkey striatum at 5 mg/kg, po measured after 2 hrs | Macaca fascicularis | 1 | organism-based format | Scientific Literature |